[Inhibition of blood coagulation in vitro by protease of Pseudomonas aeruginosa].
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D002415:Cats; D002417:Cattle; D002850:Chromatography, Gel; D004285:Dogs; D005340:Fibrinogen; D005341:Fibrinolysin / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006736:Horses; D006801:Humans; D008722:Methods; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011480:Protease Inhibitors; D011517:Prothrombin Time; D011550:Pseudomonas aeruginosa / Q000201:enzymology* / Q000472:pathogenicity; D011817:Rabbits; D012756:Sheep; D013916:Thrombelastography; D013917:Thrombin; D013997:Time Factors
D000614:Aminocaproates; D011480:Protease Inhibitors; D005340:Fibrinogen; D010447:Peptide Hydrolases; D013917:Thrombin; D005341:Fibrinolysin
Hemmung der Blutgerinnung in vitro durch Protease von Pseudomonas aeruginosa.